Free Trial

agilon health (NYSE:AGL) Shares Gap Down - Should You Sell?

agilon health logo with Medical background

Shares of agilon health, inc. (NYSE:AGL - Get Free Report) gapped down before the market opened on Wednesday . The stock had previously closed at $3.63, but opened at $3.24. agilon health shares last traded at $3.99, with a volume of 2,629,744 shares.

Analysts Set New Price Targets

A number of research analysts recently weighed in on AGL shares. Citigroup upgraded agilon health from a "sell" rating to a "neutral" rating and lifted their target price for the company from $1.75 to $2.25 in a report on Friday, January 10th. Royal Bank of Canada lifted their price objective on agilon health from $3.00 to $3.50 and gave the company an "outperform" rating in a research note on Wednesday. Macquarie began coverage on shares of agilon health in a research report on Monday, December 16th. They set a "neutral" rating and a $3.00 target price for the company. Sanford C. Bernstein lifted their price target on shares of agilon health from $2.50 to $3.15 and gave the company a "market perform" rating in a research report on Wednesday, January 15th. Finally, William Blair downgraded shares of agilon health from an "outperform" rating to a "market perform" rating in a research note on Friday, November 8th. Two analysts have rated the stock with a sell rating, thirteen have given a hold rating and two have issued a buy rating to the company's stock. Based on data from MarketBeat.com, agilon health presently has a consensus rating of "Hold" and an average price target of $3.95.

Read Our Latest Analysis on AGL

agilon health Stock Down 6.9 %

The company has a market capitalization of $1.29 billion, a price-to-earnings ratio of -3.32 and a beta of 0.67. The company has a quick ratio of 1.29, a current ratio of 1.29 and a debt-to-equity ratio of 0.06. The firm has a 50 day moving average price of $2.96 and a two-hundred day moving average price of $3.01.

Insider Buying and Selling at agilon health

In related news, Director John William Wulf purchased 45,000 shares of the business's stock in a transaction that occurred on Thursday, December 5th. The shares were purchased at an average cost of $2.18 per share, with a total value of $98,100.00. Following the completion of the acquisition, the director now directly owns 206,133 shares of the company's stock, valued at approximately $449,369.94. The trade was a 27.93 % increase in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Karen Mcloughlin acquired 25,000 shares of the firm's stock in a transaction on Friday, December 13th. The shares were bought at an average cost of $2.20 per share, with a total value of $55,000.00. Following the completion of the acquisition, the director now owns 73,166 shares in the company, valued at $160,965.20. This represents a 51.90 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders acquired a total of 77,500 shares of company stock worth $169,600 in the last 90 days. 3.20% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On agilon health

A number of institutional investors have recently modified their holdings of the stock. Vanguard Group Inc. increased its holdings in agilon health by 0.9% in the fourth quarter. Vanguard Group Inc. now owns 31,112,407 shares of the company's stock valued at $59,114,000 after buying an additional 272,787 shares during the last quarter. Capital International Investors grew its position in shares of agilon health by 72.0% in the 4th quarter. Capital International Investors now owns 22,331,873 shares of the company's stock worth $42,431,000 after acquiring an additional 9,346,295 shares in the last quarter. State Street Corp grew its position in shares of agilon health by 3.0% in the 3rd quarter. State Street Corp now owns 7,449,706 shares of the company's stock worth $29,277,000 after acquiring an additional 215,733 shares in the last quarter. Millennium Management LLC increased its holdings in shares of agilon health by 187.8% in the 4th quarter. Millennium Management LLC now owns 7,212,525 shares of the company's stock valued at $13,704,000 after acquiring an additional 4,706,357 shares during the last quarter. Finally, Geode Capital Management LLC raised its position in shares of agilon health by 0.5% during the 4th quarter. Geode Capital Management LLC now owns 6,928,724 shares of the company's stock valued at $13,168,000 after acquiring an additional 35,207 shares in the last quarter.

agilon health Company Profile

(Get Free Report)

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.

Further Reading

Should You Invest $1,000 in agilon health Right Now?

Before you consider agilon health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and agilon health wasn't on the list.

While agilon health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

3 AI Stocks to Watch After NVIDIA’s Dip

3 AI Stocks to Watch After NVIDIA’s Dip

NVIDIA may be down, but the AI boom isn’t slowing anytime soon! While investors react to short-term price swings, smart money is looking at three stocks that could benefit from NVIDIA’s continued domi

Related Videos

5 Stocks to BUY NOW in March 2025
NVIDIA Revenue SOARS 78%, But Volatility Won’t STOP!
NVIDIA Earnings: Will it Spark a Rally or Trigger a Sell-Off?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines